Many botanical-supplement users follow on/off cycling rather than continuous daily use. Here is what the user-report literature suggests for blushwood berry (EBC-46) extracts.
A look at the seed biology and germination physiology of Fontainea picrosperma — the rainforest tree that produces the blushwood berry — and what botanical research has documented.
Inclusion and exclusion criteria are the gatekeepers of every clinical trial. Here is how they have been used to shape patient selection in tigilanol tiglate (EBC-46) studies.
Reactive oxygen species generation is one of several stress signals associated with tigilanol tiglate (EBC-46) exposure. Here’s what the research literature describes.
How Switzerland classifies blushwood berry (EBC-46) products under federal food-supplement and therapeutic-product law, and what this means for buyers comparing labels.
How tincture concentration varies across blushwood berry extract supplements on the market, and what user reports say about strength, dosing, and consistency.
How insect herbivory pressure has shaped seed defensive chemistry in Fontainea picrosperma — and why blushwood berries concentrate tigilanol tiglate in their seed coat.
How dose-limiting toxicity is defined and adjudicated in Phase I oncology trials of tigilanol tiglate, and what these definitions mean for trial readouts.
How ferroptosis — iron-catalysed lipid peroxidation cell death — interacts with EBC-46 / tigilanol tiglate signalling and the surrounding research literature.
How Argentina's ANMAT regulates botanical dietary supplements and what classification pathway applies to blushwood berry extract products in 2026.
consumer
Practical storage considerations for blushwood berry extract supplements — bottle materials, light, temperature, expiry dates, and what user reports suggest about real-world shelf life.
Botany
A look at the floral biology, pollinators, and reproductive ecology of Fontainea picrosperma — the small rainforest tree that produces blushwood berry, the source of EBC-46.